Terms: = Ovarian cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
185 results:
1. TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of mcl-1.
Cai Y; Li Y; Xu Y; Yang W; Huang M
FASEB J; 2024 Apr; 38(8):e23625. PubMed ID: 38661028
[TBL] [Abstract] [Full Text] [Related]
2. WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin.
Yang J; Li N; Zhao X; Guo W; Wu Y; Nie C; Yuan Z
Biochem Pharmacol; 2024 Mar; 221():116040. PubMed ID: 38311257
[TBL] [Abstract] [Full Text] [Related]
3. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in ovarian cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract] [Full Text] [Related]
4. Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
Nolan J; Buchanan J; Taylor J; Almeida J; Bedenham T; Blair E; Broadgate S; Butler S; Cazeaux A; Craft J; Cranston T; Crawford G; Forrest J; Gabriel J; George E; Gillen D; Haeger A; Hastings Ward J; Hawkes L; Hodgkiss C; Hoffman J; Jones A; Karpe F; Kasperaviciute D; Kovacs E; Leigh S; Limb E; Lloyd-Jani A; Lopez J; Lucassen A; McFarlane C; O'Rourke AW; Pond E; Sherman C; Stewart H; Thomas E; Thomas S; Thomas T; Thomson K; Wakelin H; Walker S; Watson M; Williams E; Ormondroyd E
Genet Med; 2024 Mar; 26(3):101051. PubMed ID: 38131308
[TBL] [Abstract] [Full Text] [Related]
5. Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Tüchler A; De Pauw A; Ernst C; Anota A; Lakeman IMM; Dick J; van der Stoep N; van Asperen CJ; Maringa M; Herold N; Blümcke B; Remy R; Westerhoff A; Stommel-Jenner DJ; Frouin E; Richters L; Golmard L; Kütting N; Colas C; Wappenschmidt B; Rhiem K; Devilee P; Stoppa-Lyonnet D; Schmutzler RK; Hahnen E
Breast; 2024 Feb; 73():103615. PubMed ID: 38061307
[TBL] [Abstract] [Full Text] [Related]
6. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic Analysis and Molecular Profiling of ovarian Steroid Cell Tumors.
Mendoza RP; Wang P; Smith HL; Fitzpatrick CA; Haridas R; Wanjari P; Briese R; Shahid A; McCluggage WG; Bennett JA
Am J Surg Pathol; 2023 Dec; 47(12):1398-1408. PubMed ID: 37796179
[TBL] [Abstract] [Full Text] [Related]
8. Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E; Di Martile M; Brignone M; Di Caprio M; Manni I; Chiappa M; Sergio I; Chiacchiarini M; Bazzichetto C; Conciatori F; D'Aguanno S; D'Angelo C; Ragno R; Russillo M; Colotti G; Marchesi F; Bellone ML; Dal Piaz F; Felli MP; Damia G; Del Bufalo D
Cell Death Dis; 2023 Jul; 14(7):441. PubMed ID: 37460459
[TBL] [Abstract] [Full Text] [Related]
9. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
[TBL] [Abstract] [Full Text] [Related]
10. Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity.
Huang SL; Chang TC; Sun NK
Biochem Pharmacol; 2023 Jun; 212():115581. PubMed ID: 37146834
[TBL] [Abstract] [Full Text] [Related]
11. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
Acevedo F; Walbaum B; Camus M; Manzor M; Muñiz S; Medina L; Petric M; Reyes P; Domínguez F; Puschel K; Merino T; Bravo ML; Pinto MP; Ibáñez C; Hughes K; Sánchez C
Breast Cancer Res Treat; 2023 Jun; 199(2):363-370. PubMed ID: 36988750
[TBL] [Abstract] [Full Text] [Related]
12. Family History of Prostate cancer and Survival Outcomes in the UK Genetic Prostate cancer Study.
Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.
Negri S; De Ponti E; Sina FP; Sala E; Dell'Oro C; Roversi G; Lazzarin S; Delle Marchette M; Inzoli A; Toso C; Fumagalli S; Campanella M; Kotsopoulos J; Fruscio R
Mol Genet Genomic Med; 2022 Dec; 10(12):e2071. PubMed ID: 36307994
[TBL] [Abstract] [Full Text] [Related]
14. TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.
Wang X; Fu Y; Xing Y
Clinics (Sao Paulo); 2022; 77():100122. PubMed ID: 36288633
[TBL] [Abstract] [Full Text] [Related]
15. LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization.
Yin L; Liu X; Wu J; Yang J; Wang J; Dou H; Hou Y
Melanoma Res; 2022 Dec; 32(6):419-427. PubMed ID: 36094494
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR ovarian cancer Cell via mTORC1/S6K Signaling Pathway.
Kim G; Jang SK; Kim YJ; Jin HO; Bae S; Hong J; Park IC; Lee JH
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955892
[TBL] [Abstract] [Full Text] [Related]
17. Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes.
Burnell M; Gaba F; Sobocan M; Desai R; Sanderson S; Loggenberg K; Gessler S; Side L; Brady AF; Dorkins H; Wallis Y; Jacobs C; Legood R; Beller U; Tomlinson I; Wardle J; Menon U; Jacobs I; Manchanda R
BJOG; 2022 Nov; 129(12):1970-1980. PubMed ID: 35781768
[TBL] [Abstract] [Full Text] [Related]
18. Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.
Yuan X; Zhou Q; Zhang F; Zheng W; Liu H; Chen A; Tao Y
Gene; 2022 Sep; 838():146701. PubMed ID: 35777713
[TBL] [Abstract] [Full Text] [Related]
19. Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human ovarian cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways.
Therachiyil L; Krishnankutty R; Ahmad F; Mateo JM; Uddin S; Korashy HM
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742838
[TBL] [Abstract] [Full Text] [Related]
20. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
[TBL] [Abstract] [Full Text] [Related]
[Next]
